Metabolic syndrome increases operative mortality in patients with impaired left ventricular systolic function who undergo coronary artery bypass grafting: a retrospective observational study
Metabolic syndrome (MetS) is a prevalent risk factor for coronary artery disease progression. Past studies have shown that MetS and its components tends to increase mortality after coronary artery bypass graft...
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Shuangkun Chen, Jiahui Li, Qianzhen Li, Zhihuang Qiu, Xijie Wu and Liangwan Chen Tags: Research article Source Type: research
More News: Cardiology | Cardiovascular | Coronary Artery Bypass Graft | Heart | Metabolic Syndrome | Study